2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow CssBA: new trials by email Literature Review of CssBA trials Research Report on CssBA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults B7A (ETEC challenge strain), CssBA, dmLT - Escherichia Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2025-03-31 | 2026-04-17 |
| Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC) CssBA, dmLT - Diarrhea | Phase 1 | Completed | PATH | 50 | 2018-01-16 | 2021-01-06 |
Diarrhea (2) · Escherichia coli Infections (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · PATH (1)
United States (2)
5UM1AI148684-04 (1)